These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23137950)

  • 1. When, where, and how does Alzheimer's disease start?
    Fox N
    Lancet Neurol; 2012 Dec; 11(12):1017-8. PubMed ID: 23137950
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics of Alzheimer's disease].
    Akinori M; Ryozo K
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2122-7. PubMed ID: 16411440
    [No Abstract]   [Full Text] [Related]  

  • 4. Very early-onset sporadic Alzheimer's disease with a de novo mutation in the PSEN1 gene.
    Lou F; Luo X; Li M; Ren Y; He Z
    Neurobiol Aging; 2017 May; 53():193.e1-193.e5. PubMed ID: 28131463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
    Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
    Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
    Gallo M; Frangipane F; Cupidi C; De Bartolo M; Turone S; Ferrari C; Nacmias B; Grimaldi G; Laganà V; Colao R; Bernardi L; Anfossi M; Conidi ME; Vasso F; Curcio SAM; Mirabelli M; Smirne N; Torchia G; Muraca MG; Puccio G; Di Lorenzo R; Piccininni M; Tedde A; Maletta RG; Sorbi S; Bruni AC
    Neurobiol Aging; 2017 Aug; 56():213.e7-213.e12. PubMed ID: 28532646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic underpinnings in Alzheimer's disease - a review.
    Moustafa AA; Hassan M; Hewedi DH; Hewedi I; Garami JK; Al Ashwal H; Zaki N; Seo SY; Cutsuridis V; Angulo SL; Natesh JY; Herzallah MM; Frydecka D; Misiak B; Salama M; Mohamed W; El Haj M; Hornberger M
    Rev Neurosci; 2018 Jan; 29(1):21-38. PubMed ID: 28949931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenilin E318G variant and Alzheimer's disease risk: the Cache County study.
    Hippen AA; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS
    BMC Genomics; 2016 Jun; 17 Suppl 3(Suppl 3):438. PubMed ID: 27357204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previously not recognized deletion in presenilin-1 (p.Leu174del.) in a patient with early-onset familial Alzheimer's disease.
    Tiedt HO; Lueschow A; Winter P; Müller U
    Neurosci Lett; 2013 Jun; 544():115-8. PubMed ID: 23583593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endpoints in preclinical Alzheimer's disease trials.
    Reiman EM; Langbaum JB; Tariot PN
    J Clin Psychiatry; 2014 Jun; 75(6):661-2. PubMed ID: 25004189
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease: perspectives for the new millennium.
    Sisodia SS
    J Clin Invest; 1999 Nov; 104(9):1169-70. PubMed ID: 10545514
    [No Abstract]   [Full Text] [Related]  

  • 12. Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene.
    Golan MP; Styczyńska M; Jóźwiak K; Walecki J; Maruszak A; Pniewski J; Lugiewicz R; Filipek S; Zekanowski C; Barcikowska M
    Exp Neurol; 2007 Dec; 208(2):264-8. PubMed ID: 17931627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease.
    Larner AJ; Ray PS; Doran M
    J Neurol Sci; 2007 Jan; 252(2):173-6. PubMed ID: 17188713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer's disease and spastic paraparesis.
    Raman A; Lin X; Suri M; Hewitt M; Constantinescu CS; Phillips MF
    J Neurol Sci; 2007 Sep; 260(1-2):78-82. PubMed ID: 17507029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counseling and presenilin-1 Alzheimer's disease: "Research Family" members share some thoughts.
    Nee LE
    Am J Alzheimers Dis Other Demen; 2007; 22(2):99-102. PubMed ID: 17545136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in genetic testing for Alzheimer's disease.
    Howard KL; Filley CM
    Rev Neurol Dis; 2009; 6(1):26-32. PubMed ID: 19367221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: clinical, neuroimaging, and neuropathological findings.
    Kim J; Bagyinszky E; Chang YH; Choe G; Choi BO; An SS; Kim S
    Neurosci Lett; 2012 Nov; 530(2):109-14. PubMed ID: 23046926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic study of familial cases of Alzheimer's disease.
    Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
    Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel presenilin 1 mutation (p.I83T) in Tunisian family with early-onset Alzheimer's disease.
    Achouri-Rassas A; Ben Ali N; Fray S; Hadj Fredj S; Kechaou M; Zakraoui NO; Cherif A; Chabbi S; Anane N; Messaoud T; Gouider R; Belal S
    Neurobiol Aging; 2015 Oct; 36(10):2904.e9-11. PubMed ID: 26145164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update.
    Larner AJ; Doran M
    J Alzheimers Dis; 2009; 17(2):259-65. PubMed ID: 19221408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.